Bath & Body Works shares are trading lower after the company reported worse-than-expected Q2 sales results and issued FY24 adjusted EPS guidance with its midpoint below estimates. Also, the company issued Q3 EPS guidance below estimates.
Portfolio Pulse from Benzinga Newsdesk
Bath & Body Works shares declined following disappointing Q2 sales results and lower-than-expected FY24 and Q3 EPS guidance.

August 28, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bath & Body Works reported Q2 sales below expectations and issued FY24 and Q3 EPS guidance that fell short of estimates, leading to a decline in share price.
The company's Q2 sales results were worse than expected, and the guidance for FY24 and Q3 EPS was below estimates. This negative financial performance and outlook are likely to lead to a decrease in investor confidence, resulting in a short-term decline in the stock price.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100